Literature DB >> 26901668

TRPM3 gating in planar lipid bilayers defines peculiar agonist specificity.

Lusine Demirkhanyan1, Kunitoshi Uchida1,2,3, Makoto Tominaga2,3, Eleonora Zakharian1.   

Abstract

Entities:  

Keywords:  PIP2; PS; Planar Lipid Bilayers; TRPM3; Transient Receptor Potential Melastatin 3 channel; phosphatidylinositol-4,5-bisphosphate; pregnenolone sulfate

Mesh:

Substances:

Year:  2016        PMID: 26901668      PMCID: PMC4954575          DOI: 10.1080/19336950.2016.1155900

Source DB:  PubMed          Journal:  Channels (Austin)        ISSN: 1933-6950            Impact factor:   2.581


× No keyword cloud information.
TRP channels are remarkable in their functional diversity. The Melastatin group representative TRPM3 is no exception. TRPM3 has been implicated in diverse physiological processes, ranging from inflammatory hyperalgesia in somatosensory neurons to glucose-induced insulin release in pancreatic β-cells. In addition to the expression of TRPM3 in the indicated tissues, the variety of its functional contributions is modulated by the diverse stimuli that regulate TRPM3 channel activity. Indeed, in native and heterologous cellular systems, TRPM3 activity is driven by various endogenous and exogenous factors, including temperature and number of chemical compounds. To determine agonist-specific TRPM3 channel functions we aimed to reconstitute TRPM3 in the planar lipid bilayers in our recent work. The extensive biophysical analysis of TRPM3 in the bilayer system allowed defining the channel characteristics and its direct regulators. Intriguingly, after the incorporation, TRPM3 demonstrated distinctive and well-organized basal channel activity. For comparison, other TRP channels characterized in such a reconstituted system did no yield a similar activity. We suggested that the basal channel openings resemble the constitutive TRPM3 activity detected in cellular recordings. Another TRP representative that possesses similar constitutive activity in cells is TRPV6. However in the planar lipid bilayer system TRPV6 was readily stimulated with only an addition of phosphatidylinositol-4,5-bisphosphate (PIP2), which was required for its activity. Interestingly, for obtaining TRPM3 basal currents in the bilayers addition of PIP2 was not required. Even more surprising was the fact that the basal TRPM3 activity lasted only for a limited period, but was observed more often in the complete absence of Mg2+. These results indicated that channel activity is finely tuned by cations. In agreement with this, earlier studies by Oberwinkler et al. demonstrated that TRPM3 activity is tightly controlled by both monovalent and divalent cations, as evidenced by whole-cell patch clamp recordings. Therefore, the inactivation of the constitutive activity in the bilayers could be causative of the certain inhibitory effects exerted by cations. Recent studies indicated that one of the prominent endogenous agonists of TRPM3 channels is a neurosteroid, pregnenolone sulfate (PS). Appreciating its physiological significance, we evaluated the effects PS exerts on TRPM3 in the bilayer system. These experiments supported a direct agonistic PS action on TRPM3 gating, although PS alone was insufficient and required a co-factor for its activity. Hence, PS evoked TRPM3 openings occurred only in the presence of PIP2 or clotrimazole. TRPM3 regulation by phosphoinositides was similarly observed in patch clamp recordings, indicating their physiological role in channel activity. However, in comparison to other PIP2-regulated TRP channels, TRPM3 dependence was much less. The critical part of this analogy is that TRPM3 needed PIP2 only under some conditions, while for the other PIP2-dependent TRP channels its presence was essential at all times. For instance, previously characterized TRP channels in our lab, including TRPM8, TRPV6, and TRPV1, absolutely required the presence of PIP2 in the bilayers to induce their channel activity with all the stimuli. Another agonist that has been previously detected for TRPM3 is nifedipine. Nifedipine is a pharmacological compound and an inhibitor of L-type voltage-gated Ca2+ channels. Unlike PS, nifedipine activated TRPM3 with a different gating mode and did not require any additives. These results indicate that PS and nifedipine act on the channel differently, which is in agreement with the allosteric activation of TRPM3 by these compounds observed in cells. One of the important TRPM3 activities was linked to temperature sensation. To establish the role of TRPM3 in heat-induced activity, we evaluated its temperature sensitivity in bilayers. In contrast to cell recordings, we could not potentiate TRPM3 opening by exposing it to heat alone or in the presence of PS. Taking into consideration that temperature-induced activation of the cold receptor, TRPM8, and the heat receptor, TRPV1, is effectively achieved in bilayers in the presence of their permanent gating factor – PIP2, we wondered whether PIP2 could also contribute to temperature-induced gating of TRPM3. Testing the addition of PIP2 to bilayers upon heat-induced activation of TRPM3 indeed was more efficient, yet it could not stimulate sufficient conformational changes of the protein to extend it to the fully open channel and only exhibited a low open probability mode. Furthermore, the thermodynamic analysis indicated that intrinsically TRPM3 is only slightly temperature dependent, in comparison to highly temperature sensitive TRPM8 and TRPV1. In conclusion, in our recent work, we provided insights into the mechanism of TRPM3 channel gating. In parallel with the earlier reports obtained from cell recordings, in planar lipid bilayers TRPM3 was directly activated by PS and depended on the presence of PIP2 (Fig. 1). On the other hand, we did not observe previously reported temperature sensitivity of TRPM3. Despite its strong heat-induced activity and current potentiation in cells, in the artificial system TRPM3 is only slightly temperature sensitive and could not transition into the fully open conformation when exposed to heat. These channel characteristics along with the basal activity indicated an existence of other endogenous factors that regulate TRPM3 in cells.
Figure 1.

The activity of the TRPM3 channel reconstituted in planar lipid bilayers. The model and recordings of TRPM3 in the bilayers: Top traces: Basal TRPM3 activity, regularly obtained and characterized by its complete inactivation within ˜10 min. Middle traces: TRPM3 activity induced by 5 μM pregnenolone sulfate (PS) in the presence of 5 μM phosphatidylinositol-4, 5-bisphosphate (PIP2). Lower traces: Heat-induced TRPM3 exhibits low open probability in the presence of PIP2. All recording were obtained at 100 mV.

The activity of the TRPM3 channel reconstituted in planar lipid bilayers. The model and recordings of TRPM3 in the bilayers: Top traces: Basal TRPM3 activity, regularly obtained and characterized by its complete inactivation within ˜10 min. Middle traces: TRPM3 activity induced by 5 μM pregnenolone sulfate (PS) in the presence of 5 μM phosphatidylinositol-4, 5-bisphosphate (PIP2). Lower traces: Heat-induced TRPM3 exhibits low open probability in the presence of PIP2. All recording were obtained at 100 mV.
  8 in total

1.  Alternative splicing switches the divalent cation selectivity of TRPM3 channels.

Authors:  Johannes Oberwinkler; Annette Lis; Klaus M Giehl; Veit Flockerzi; Stephan E Philipp
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

2.  Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic beta cells.

Authors:  Thomas F J Wagner; Sabine Loch; Sachar Lambert; Isabelle Straub; Stefanie Mannebach; Ilka Mathar; Martina Düfer; Annette Lis; Veit Flockerzi; Stephan E Philipp; Johannes Oberwinkler
Journal:  Nat Cell Biol       Date:  2008-11-02       Impact factor: 28.824

3.  Intracellular ATP supports TRPV6 activity via lipid kinases and the generation of PtdIns(4,5) P₂.

Authors:  Eleonora Zakharian; Chike Cao; Tibor Rohacs
Journal:  FASEB J       Date:  2011-08-02       Impact factor: 5.191

4.  Regulation of the temperature-dependent activation of transient receptor potential vanilloid 1 (TRPV1) by phospholipids in planar lipid bilayers.

Authors:  Xiaohui Sun; Eleonora Zakharian
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

5.  Stimulation-dependent gating of TRPM3 channel in planar lipid bilayers.

Authors:  Kunitoshi Uchida; Lusine Demirkhanyan; Swapna Asuthkar; Alejandro Cohen; Makoto Tominaga; Eleonora Zakharian
Journal:  FASEB J       Date:  2015-12-09       Impact factor: 5.191

6.  Regulation of the transient receptor potential channel TRPM3 by phosphoinositides.

Authors:  Balázs I Tóth; Maik Konrad; Debapriya Ghosh; Florian Mohr; Christian R Halaszovich; Michael G Leitner; Joris Vriens; Johannes Oberwinkler; Thomas Voets
Journal:  J Gen Physiol       Date:  2015-07       Impact factor: 4.086

7.  Transient receptor potential melastatin 3 is a phosphoinositide-dependent ion channel.

Authors:  Doreen Badheka; Istvan Borbiro; Tibor Rohacs
Journal:  J Gen Physiol       Date:  2015-07       Impact factor: 4.086

8.  Inorganic polyphosphate modulates TRPM8 channels.

Authors:  Eleonora Zakharian; Baskaran Thyagarajan; Robert J French; Evgeny Pavlov; Tibor Rohacs
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

  8 in total
  2 in total

1.  Bradykinin-Induced Sensitization of Transient Receptor Potential Channel Melastatin 3 Calcium Responses in Mouse Nociceptive Neurons.

Authors:  Marc Behrendt; Hans Jürgen Solinski; Martin Schmelz; Richard Carr
Journal:  Front Cell Neurosci       Date:  2022-04-13       Impact factor: 5.505

2.  The structural basis for an on-off switch controlling Gβγ-mediated inhibition of TRPM3 channels.

Authors:  Marc Behrendt; Fabian Gruss; Raissa Enzeroth; Sandeep Dembla; Siyuan Zhao; Pierre-Antoine Crassous; Florian Mohr; Mieke Nys; Nikolaos Louros; Rodrigo Gallardo; Valentina Zorzini; Doris Wagner; Anastassios Economou; Frederic Rousseau; Joost Schymkowitz; Stephan E Philipp; Tibor Rohacs; Chris Ulens; Johannes Oberwinkler
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-29       Impact factor: 12.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.